about
Brachytherapy in non melanoma skin cancer of eyelid: a systematic reviewPelvic radiation disease: Updates on treatment optionsClinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approachDoes downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patientsDietary anthocyanins and health: data from FLORA and ATHENA EU projects.Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer.Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma.Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas.INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures.Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies.A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases.Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience.Adjuvant radiotherapy in resectable pancreatic carcinoma.Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study.Robotic radiosurgery in pancreatic cancer: A systematic review.Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation studyProgestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment.Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trialPlanning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review.Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancerA surgical multi-layer technique for pelvic reconstruction after total exenteration using a combination of pedicled omental flap, human acellular dermal matrix and autologous adipose derived cells.Radioprotective effect of moderate wine consumption in patients with breast carcinoma.A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer.Intensity modulated radiation therapy for breast cancer: current perspectivesChemoradiation and brachytherapy in extrahepatic bile duct carcinoma.Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy.Volumetric modulated arc therapy for treatment of solid tumors: current insights.Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review.Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: a Phase II study.Metachronous solitary metastasis to the thyroid gland from squamous cell carcinoma of the lung: a case report and literature review.Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies.Multimodal treatment of resectable pancreatic ductal adenocarcinoma.Palliative electro-chemotherapy in elderly patients with vulvar cancer: A phase II trial.Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases.Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study.Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial.Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
P50
Q26774100-22852F77-154C-4BEA-BA4D-12E0AB9F21B8Q26775088-D260C4FE-9AAA-4FDC-B64F-99A3EC00D726Q26862365-814B4025-34CA-4F77-9A43-C7424F975F91Q28204276-4A266110-1335-4445-9C1E-A0F2CD9FE3CEQ30251710-8206F7A8-08DB-46A3-A8B0-1623A065BD24Q30459120-643E69D4-6E57-4737-B36D-C2AEDD0A4DDFQ33334084-DF57CE24-4A51-4194-A04B-952630AB8AF6Q33903582-13C0DAA4-529E-47E1-B7DD-79D3527DB14DQ33903591-BA20B9F5-44C0-4618-81BE-8E960D7F3086Q34295064-75B5DFAC-8D3A-4FAA-85E5-AAD448606187Q34386983-A6986A1C-0E0F-414D-B57C-F665BF88C93BQ34667324-6D8D4694-F0AD-432B-A131-21A33B5F84B5Q34825150-B7D16310-FAC8-4A73-AA37-EBB161647FA0Q35633819-37EE1D50-056B-4982-957F-76769FF78A1CQ35970200-0B40D517-E06E-4954-A755-FB3CD0D09FDEQ36369033-CAB78AD2-74D8-4748-9DE9-6868F93C21ADQ36550570-03BA13BD-A482-45D4-97F0-3A081AF517B6Q36825389-E2438C30-8E53-45FC-8B32-F874FF68BFD8Q36980782-28248FFD-194D-48C1-BA92-751A199ECF4EQ37127154-0FD60105-F9AC-4139-B982-FBA231510DB4Q37176814-759ACCD3-AC30-40EE-BD81-1EE1E643EAC0Q37396914-8F5DAA2F-5A2D-4018-9B41-CE290FABFB6FQ37460391-8DE14802-7B5E-4EAE-8F94-7358469090F6Q37621308-590452DA-3AD6-4ACE-8341-203EB073D991Q37693450-B7CDFC23-D033-4E7D-8374-E957DAB9F4A8Q38167407-20886E55-7CD0-4266-B059-09AED0007B05Q38216239-F77545A7-8611-46F5-9545-F527B6EF1C2AQ38631481-BAEA7D1F-3A49-47C0-AF3E-F0AE15C43137Q38665086-FFA9FA52-3D8E-48FB-90F2-E12C88EFD6E0Q38667997-D5651E2A-82A1-4FEE-9D33-F1F9D3C5590FQ38913962-351661EF-CAE3-4B35-99C0-164C2F565521Q38996107-37B8A232-8DDB-43FF-86B5-AD8F61EA52FBQ39095479-BE3F25B4-B422-4BF9-8604-0A0B4F142E2FQ39161424-08869FE4-DB63-46A2-9CB9-10934ADB0238Q39183757-AD2477A3-8C69-4127-B311-F96438D825D8Q39185766-EB2207E1-695F-40B9-8E8F-51F0252B2B19Q39247968-41CA63AA-FD21-4430-9203-A11C671D0EBEQ39342639-462B5E82-2D4C-4255-A409-C7AB32B04735Q39360193-1F117402-7E75-40C5-94CD-AC1B356CEF80Q39378011-D4504D15-0B7F-437A-B8C0-7BBA84D23900
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alessio G Morganti
@ast
Alessio G Morganti
@en
Alessio G Morganti
@es
Alessio G Morganti
@nl
type
label
Alessio G Morganti
@ast
Alessio G Morganti
@en
Alessio G Morganti
@es
Alessio G Morganti
@nl
prefLabel
Alessio G Morganti
@ast
Alessio G Morganti
@en
Alessio G Morganti
@es
Alessio G Morganti
@nl
P106
P1153
7007092215
P21
P31
P496
0000-0001-9793-3410